China ADHD Drugs Market Report & Forecast 2021-2027

Publisher Name :
Date: 15-Dec-2021
No. of pages: 92
Inquire Before Buying

China ADHD Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)

China ADHD Drugs Market Segment Percentages, By Type, 2020 (%)

- Stimulants(Amphetamines, Methylphenidate)

- Non-Stimulants

- Antidepressants

- Blood Pressure Medicines

China ADHD Drugs Market, By User, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)

China ADHD Drugs Market Segment Percentages, By User, 2020 (%)

- Adults

- Children

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies ADHD Drugs revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies ADHD Drugs revenues share in China market, 2020 (%)

Key companies ADHD Drugs sales in China market, 2016-2021 (Estimated), (K Pcs)

Key companies ADHD Drugs sales share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Eli Lilly

- Janssen Pharmaceuticals, Inc.

- Takeda

- Perdue Pharma

- Glaxosmith Kline

- Novartis

- Celltech Group

- Johnson & Johnson

China ADHD Drugs Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 ADHD Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by User
1.3 China ADHD Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China ADHD Drugs Overall Market Size
2.1 China ADHD Drugs Market Size: 2021 VS 2027
2.2 China ADHD Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 China ADHD Drugs Sales: 2016-2027
3 Company Landscape
3.1 Top ADHD Drugs Players in China Market
3.2 Top China ADHD Drugs Companies Ranked by Revenue
3.3 China ADHD Drugs Revenue by Companies
3.4 China ADHD Drugs Sales by Companies
3.5 China ADHD Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 ADHD Drugs Companies in China Market, by Revenue in 2020
3.7 Manufacturers ADHD Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 ADHD Drugs Players in China Market
3.8.1 List of Tier 1 ADHD Drugs Companies in China
3.8.2 List of Tier 2 and Tier 3 ADHD Drugs Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China ADHD Drugs Market Size Markets, 2021 & 2027
4.1.2 Stimulants(Amphetamines, Methylphenidate)
4.1.3 Non-Stimulants
4.1.4 Antidepressants
4.1.5 Blood Pressure Medicines
4.2 By Type - China ADHD Drugs Revenue & Forecasts
4.2.1 By Type - China ADHD Drugs Revenue, 2016-2021
4.2.2 By Type - China ADHD Drugs Revenue, 2022-2027
4.2.3 By Type - China ADHD Drugs Revenue Market Share, 2016-2027
4.3 By Type - China ADHD Drugs Sales & Forecasts
4.3.1 By Type - China ADHD Drugs Sales, 2016-2021
4.3.2 By Type - China ADHD Drugs Sales, 2022-2027
4.3.3 By Type - China ADHD Drugs Sales Market Share, 2016-2027
4.4 By Type - China ADHD Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by User
5.1 Overview
5.1.1 By User - China ADHD Drugs Market Size, 2021 & 2027
5.1.2 Adults
5.1.3 Children
5.2 By User - China ADHD Drugs Revenue & Forecasts
5.2.1 By User - China ADHD Drugs Revenue, 2016-2021
5.2.2 By User - China ADHD Drugs Revenue, 2022-2027
5.2.3 By User - China ADHD Drugs Revenue Market Share, 2016-2027
5.3 By User - China ADHD Drugs Sales & Forecasts
5.3.1 By User - China ADHD Drugs Sales, 2016-2021
5.3.2 By User - China ADHD Drugs Sales, 2022-2027
5.3.3 By User - China ADHD Drugs Sales Market Share, 2016-2027
5.4 By User - China ADHD Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Overview
6.1.3 Eli Lilly ADHD Drugs Sales and Revenue in China Market (2016-2021)
6.1.4 Eli Lilly ADHD Drugs Product Description
6.1.5 Eli Lilly Recent Developments
6.2 Janssen Pharmaceuticals, Inc.
6.2.1 Janssen Pharmaceuticals, Inc. Corporation Information
6.2.2 Janssen Pharmaceuticals, Inc. Overview
6.2.3 Janssen Pharmaceuticals, Inc. ADHD Drugs Sales and Revenue in China Market (2016-2021)
6.2.4 Janssen Pharmaceuticals, Inc. ADHD Drugs Product Description
6.2.5 Janssen Pharmaceuticals, Inc. Recent Developments
6.3 Takeda
6.3.1 Takeda Corporation Information
6.3.2 Takeda Overview
6.3.3 Takeda ADHD Drugs Sales and Revenue in China Market (2016-2021)
6.3.4 Takeda ADHD Drugs Product Description
6.3.5 Takeda Recent Developments
6.4 Perdue Pharma
6.4.1 Perdue Pharma Corporation Information
6.4.2 Perdue Pharma Overview
6.4.3 Perdue Pharma ADHD Drugs Sales and Revenue in China Market (2016-2021)
6.4.4 Perdue Pharma ADHD Drugs Product Description
6.4.5 Perdue Pharma Recent Developments
6.5 Glaxosmith Kline
6.5.1 Glaxosmith Kline Corporation Information
6.5.2 Glaxosmith Kline Overview
6.5.3 Glaxosmith Kline ADHD Drugs Sales and Revenue in China Market (2016-2021)
6.5.4 Glaxosmith Kline ADHD Drugs Product Description
6.5.5 Glaxosmith Kline Recent Developments
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Overview
6.6.3 Novartis ADHD Drugs Sales and Revenue in China Market (2016-2021)
6.6.4 Novartis ADHD Drugs Product Description
6.6.5 Novartis Recent Developments
6.7 Celltech Group
6.7.1 Celltech Group Corporation Information
6.7.2 Celltech Group Overview
6.7.3 Celltech Group ADHD Drugs Sales and Revenue in China Market (2016-2021)
6.7.4 Celltech Group ADHD Drugs Product Description
6.7.5 Celltech Group Recent Developments
6.8 Johnson & Johnson
6.8.1 Johnson & Johnson Corporation Information
6.8.2 Johnson & Johnson Overview
6.8.3 Johnson & Johnson ADHD Drugs Sales and Revenue in China Market (2016-2021)
6.8.4 Johnson & Johnson ADHD Drugs Product Description
6.8.5 Johnson & Johnson Recent Developments
7 China ADHD Drugs Production Capacity, Analysis
7.1 China ADHD Drugs Production Capacity, 2016-2027
7.2 ADHD Drugs Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 ADHD Drugs Supply Chain Analysis
9.1 ADHD Drugs Industry Value Chain
9.2 ADHD Drugs Upstream Market
9.3 ADHD Drugs Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 ADHD Drugs Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of ADHD Drugs in China Market
Table 2. Top ADHD Drugs Players in China Market, Ranking by Revenue (2019)
Table 3. China ADHD Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China ADHD Drugs Revenue Share by Companies, 2016-2021
Table 5. China ADHD Drugs Sales by Companies, (K Pcs), 2016-2021
Table 6. China ADHD Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers ADHD Drugs Price (2016-2021) & (USD/Pcs)
Table 8. Manufacturers ADHD Drugs Product Type
Table 9. List of Tier 1 ADHD Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 ADHD Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Stimulants(Amphetamines, Methylphenidate)
Table 12. Major Manufacturers of Non-Stimulants
Table 13. By Type - China ADHD Drugs Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China ADHD Drugs Revenue (US$, Mn), 2016-2021
Table 15. By Type - China ADHD Drugs Revenue (US$, Mn), 2022-2027
Table 16. By Type - China ADHD Drugs Sales (K Pcs), 2016-2021
Table 17. By Type - China ADHD Drugs Sales (K Pcs), 2022-2027
Table 18. By User - China ADHD Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 19. By User - China ADHD Drugs Revenue (US$, Mn), 2016-2021
Table 20. By User - China ADHD Drugs Revenue (US$, Mn), 2022-2027
Table 21. By User - China ADHD Drugs Sales (K Pcs), 2016-2021
Table 22. By User - China ADHD Drugs Sales (K Pcs), 2022-2027
Table 23. Eli Lilly Corporation Information
Table 24. Eli Lilly Description and Major Businesses
Table 25. Eli Lilly ADHD Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 26. Eli Lilly ADHD Drugs Product
Table 27. Eli Lilly Recent Developments
Table 28. Janssen Pharmaceuticals, Inc. Corporation Information
Table 29. Janssen Pharmaceuticals, Inc. Description and Major Businesses
Table 30. Janssen Pharmaceuticals, Inc. ADHD Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 31. Janssen Pharmaceuticals, Inc. ADHD Drugs Product
Table 32. Janssen Pharmaceuticals, Inc. Recent Developments
Table 33. Takeda Corporation Information
Table 34. Takeda Description and Major Businesses
Table 35. Takeda ADHD Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 36. Takeda ADHD Drugs Product
Table 37. Takeda Recent Developments
Table 38. Perdue Pharma Corporation Information
Table 39. Perdue Pharma Description and Major Businesses
Table 40. Perdue Pharma ADHD Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 41. Perdue Pharma ADHD Drugs Product
Table 42. Perdue Pharma Recent Developments
Table 43. Glaxosmith Kline Corporation Information
Table 44. Glaxosmith Kline Description and Major Businesses
Table 45. Glaxosmith Kline ADHD Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 46. Glaxosmith Kline ADHD Drugs Product
Table 47. Glaxosmith Kline Recent Developments
Table 48. Novartis Corporation Information
Table 49. Novartis Description and Major Businesses
Table 50. Novartis ADHD Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 51. Novartis ADHD Drugs Product
Table 52. Novartis Recent Developments
Table 53. Celltech Group Corporation Information
Table 54. Celltech Group Description and Major Businesses
Table 55. Celltech Group ADHD Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 56. Celltech Group ADHD Drugs Product
Table 57. Celltech Group Recent Developments
Table 58. Johnson & Johnson Corporation Information
Table 59. Johnson & Johnson Description and Major Businesses
Table 60. Johnson & Johnson ADHD Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 61. Johnson & Johnson ADHD Drugs Product
Table 62. Johnson & Johnson Recent Developments
Table 63. ADHD Drugs Production Capacity (K Pcs) of Key Manufacturers in China Market, 2019-2021 (K Pcs)
Table 64. China ADHD Drugs Capacity Market Share of Key Manufacturers, 2019-2021
Table 65. ADHD Drugs Market Opportunities & Trends in China Market
Table 66. ADHD Drugs Market Drivers in China Market
Table 67. ADHD Drugs Market Restraints in China Market
Table 68. ADHD Drugs Raw Materials
Table 69. ADHD Drugs Raw Materials Suppliers in China Market
Table 70. Typical ADHD Drugs Downstream
Table 71. ADHD Drugs Downstream Clients in China Market
Table 72. ADHD Drugs Distributors and Sales Agents in China Market
List of Figures
Figure 1. ADHD Drugs Product Picture
Figure 2. ADHD Drugs Segment by Type
Figure 3. ADHD Drugs Segment by User
Figure 4. China ADHD Drugs Market Overview: 2020
Figure 5. China ADHD Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China ADHD Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. ADHD Drugs Sales in China Market: 2016-2027 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by ADHD Drugs Revenue in 2020
Figure 9. Stimulants(Amphetamines, Methylphenidate) Product Picture
Figure 10. Non-Stimulants Product Picture
Figure 11. Antidepressants Product Picture
Figure 12. Blood Pressure Medicines Product Picture
Figure 13. By Type - China ADHD Drugs Sales Market Share, 2016-2027
Figure 14. By Type - China ADHD Drugs Revenue Market Share, 2016-2027
Figure 15. By Type - China ADHD Drugs Price (USD/Pcs), 2016-2027
Figure 16. Adults
Figure 17. Children
Figure 18. By User - China ADHD Drugs Sales Market Share, 2016-2027
Figure 19. By User - China ADHD Drugs Revenue Market Share, 2016-2027
Figure 20. By User - China ADHD Drugs Price (USD/Pcs), 2016-2027
Figure 21. Eli Lilly ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Janssen Pharmaceuticals, Inc. ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Takeda ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Perdue Pharma ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Glaxosmith Kline ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Novartis ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Celltech Group ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Johnson & Johnson ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. China ADHD Drugs Production Capacity (K Pcs), 2016-2027
Figure 30. ADHD Drugs Industry Value Chain
Figure 31. Marketing Channels
  • Global Divalproex Sodium Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 81
    Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in The brain tissue to stop seizures. Divalproex Sodium is also used to treat The manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches. This medicine is available only with your doctor's prescription. The global Divalproex Sodium market was valued at US$ 2188.5 million in 2023 and is anticipated to reach US$ 33......
  • Global Divalproex Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Divalproex Sodium market size was valued at US$ 2140.9 million in 2023. With growing demand in downstream market, the Divalproex Sodium is forecast to a readjusted size of US$ 3312 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Divalproex Sodium market. Divalproex Sodium are expected to show stable growth in the future market. However, product differ......
  • Global Quetiapine Fumarate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Quetiapine Fumarate market size was valued at US$ 156.2 million in 2023. With growing demand in downstream market, the Quetiapine Fumarate is forecast to a readjusted size of US$ 132.9 million by 2030 with a CAGR of -2.3% during review period. The research report highlights the growth potential of the global Quetiapine Fumarate market. Quetiapine Fumarate are expected to show stable growth in the future market. However, produ......
  • Global Clozapine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Clozapine market size was valued at US$ 341.4 million in 2023. With growing demand in downstream market, the Clozapine is forecast to a readjusted size of US$ 463.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Clozapine market. Clozapine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Trazodone Hydrochloride (API) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 92
    According to our LPI (LP Information) latest study, the global Trazodone Hydrochloride (API) market size was valued at US$ million in 2023. With growing demand in downstream market, the Trazodone Hydrochloride (API) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Trazodone Hydrochloride (API) market. Trazodone Hydrochloride (API) are expected to show stable growth in the future......
  • Global Trazodone Hydrochloride (API) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 93
    According to our (Global Info Research) latest study, the global Trazodone Hydrochloride (API) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Trazodone, a phenylpiperazine-triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety an......
  • Global Divalproex Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Divalproex Sodium market size was valued at USD 2251.9 million in 2023 and is forecast to a readjusted size of USD 3371.1 million by 2030 with a CAGR of 5.9% during review period. Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in the brain tissue to stop seizures. Divalproex Sodium is also used to treat the manic phase of bipolar disorder (manic-d......
  • Global Risperidone Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 93
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Risperidone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Janssen (Johnson & Johnson) - Ajanta Pharma - Amneal Pharmaceuticals - Aurobindo Pharma - Hikma - Sandoz - Lannett - Tris Pharma - Ap......
  • Global Schizophrenia Therapeutics Market Status and Outlook 2023-2028
    Published: 27-Dec-2023        Price: US 3160 Onwards        Pages: 101
    Schizophrenia is usually treated with an individually tailored combination of talking therapy and medicine. Most people with schizophrenia are treated by community mental health teams (CMHTs). The goal of the CMHT is to provide day-to-day support and treatment while ensuring you have as much independence as possible. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market va......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs